Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72,013 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke.
Narezkina A, Akhter N, Lu X, Emond B, Panjabi S, Forbes SP, Hilts A, Liu S, Lafeuille MH, Lefebvre P, Huang Q, Choi M. Narezkina A, et al. Among authors: liu s. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):e959-e971. doi: 10.1016/j.clml.2022.07.004. Epub 2022 Jul 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35973891 Free article.
Real-world treatment, dosing, and discontinuation patterns among patients treated with pegvaliase for phenylketonuria: Evidence from dispensing data.
Lah M, Cook K, Gomes DA, Liu S, Tabatabaeepour N, Kirson N, Chen E, Lindstrom K, Whitehall KB, Van Backle J, Burton BK. Lah M, et al. Among authors: liu s. Mol Genet Metab Rep. 2022 Sep 25;33:100918. doi: 10.1016/j.ymgmr.2022.100918. eCollection 2022 Dec. Mol Genet Metab Rep. 2022. PMID: 36176956 Free PMC article.
72,013 results
You have reached the last available page of results. Please see the User Guide for more information.